Sonnenblick, A., Venet, D., Brohée, S., Pondé, N., & Sotiriou, C. (2019). pAKT pathway activation is associated with PIK3CA mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activation. NPJ Breast Cancer.
Citação norma ChicagoSonnenblick, Amir, David Venet, Sylvain Brohée, Noam Pondé, and Christos Sotiriou. "PAKT Pathway Activation Is Associated With PIK3CA Mutations and Good Prognosis in Luminal Breast Cancer in Contrast to P-mTOR Pathway Activation." NPJ Breast Cancer 2019.
MLA citiranjeSonnenblick, Amir, et al. "PAKT Pathway Activation Is Associated With PIK3CA Mutations and Good Prognosis in Luminal Breast Cancer in Contrast to P-mTOR Pathway Activation." NPJ Breast Cancer 2019.
Opozorilo: Ti citati niso vedno 100% točni.